A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
about
P1343
Cancer stem cell targeted therapy: progress amid controversies.Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge.Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.Murine models of acute leukemia: important tools in current pediatric leukemia research.The E. Donnall Thomas lecture: normal and neoplastic stem cells.Stem cells and bone diseases: new tools, new perspectiveNovel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaBSuppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.Human cancer growth and therapy in immunodeficient mouse models.Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype.Visualizing the kinetics of tumor-cell clearance in living animals.Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease modelAn in vivo model of human multidrug-resistant multiple myeloma in SCID micePotential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice.Acute myeloid leukemia stem cells.Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signalingAnti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid miceXenograft models for the preclinical evaluation of new therapies in acute leukemia.Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo.In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models.Mouse models for pre-clinical drug testing in leukemia.Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic LeukemiaHematology and oncology at the Hospital for Sick Children.Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice.Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.The SCID mouse: relevance as an animal model system for studying human disease.VLA-4 is involved in the engraftment of the human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice.Differential Hsp70 plasma-membrane expression on primary human tumors and metastases in mice with severe combined immunodeficiency.The use of SCID mice in biotechnology and as a model for human disease.BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice.Immunotoxin studies in a model of human T-cell acute lymphoblastic leukemia developed in severe combined immune-deficient mice.Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody.Characteristics and performance of a bispecific F (ab'gamma)2 antibody for delivering saporin to a CD7+ human acute T-cell leukaemia cell line.
P2860
Q26779931-0480E06F-03DB-4CBC-894A-EE8AE1CC4C3EQ33520247-D4B8182A-8521-4108-86CE-62834ACBEE8CQ33560521-FFE29A4F-C829-4D8B-ABBA-FEF88E8B0781Q33606018-CBBA65C9-1CAA-48F2-A2EF-C15E9002A4DDQ33650192-74079A42-5481-4AB4-9683-6CAD1DE85F60Q33925049-174E91F7-9112-4B89-BE4C-0EEE78817082Q34005240-A1CF0412-5DBE-4BA1-B2A9-36934F911AF4Q34541243-6ED96BBD-65AD-45C4-8D94-5D8FB44F79C8Q34582987-F0C026CD-EE27-4742-BA39-EDAE5586111AQ34975395-B6A8999B-74CA-412E-BA4C-A7CF730804B9Q35237895-0EAECC18-8D95-48F7-8022-94C104B2F21AQ35545282-681D7FF2-3AC5-4F4B-A542-51F96D9B272EQ35608278-AC2B0595-929C-48D4-BC4A-E1C5E21D2D2FQ35731839-4F079B84-9C46-4DAE-A0BB-65EFFDF96295Q35831685-A9674B20-B675-41FE-9BFD-90C3463A9B70Q35832500-98CCE4EB-A2EB-473D-A98E-DDFC142397D6Q35833430-BDBA80FE-A8F9-4FE7-8994-05677CD6E325Q35839280-73210AD5-7F9A-4543-B81E-FF473714B4C7Q35950948-17C71340-A3E6-40BF-A0E9-200FA76B7A02Q36164458-6AAE3073-D122-4AC5-B14A-22BA06514A6AQ36211488-CCDFCC46-4E86-4771-80EC-31031F4214DFQ36621599-B0670313-990A-4E2D-9E55-9788EA7DC2C4Q36799846-15265957-41DF-487C-99A2-18C2252320F1Q36816122-92C8C921-F5DE-4EFA-84FF-4B1ED0C15F1AQ37340763-A3CF10B7-8A67-4074-A76B-5D0D4275F2F3Q37856463-06D7A5F5-3C92-4C33-8D85-7FD1F1538019Q38937610-AF4855DD-460C-43B9-B8F2-14EB52D3CE49Q39132241-60F1B2B0-16A2-46FF-8DA3-68EE2E7CF61BQ39541994-B747BE74-FF3C-4D0D-A025-5FBF281CA75BQ39571861-3F9FB98F-70E5-4B8A-9FDF-319F5C2D8466Q40149789-2316F96A-1120-4DB0-8AB1-706E3C64E484Q40788237-F2FFAA2A-B615-4053-BD10-1DC2B5D9B450Q41006268-0E987CA8-B846-46D0-A117-4241CC7B0BB5Q41013037-2635C838-5065-446A-8A5E-1344D129C1E3Q41233084-BB56484F-0E42-4A56-B672-34D1B811AD8FQ41315876-F0A17D65-A2BC-41A8-8434-C0140C5E9B9EQ41493097-F3DF57EE-FEE2-49B5-9121-599CD6053B05Q41505435-1DEF90FF-A6DD-4BC3-9DA9-17285232EC53Q41632290-B8DC02EA-5521-4B3C-99F3-66A47B703CE9Q41672335-72F271CC-46BC-41FC-A9EA-403127612E97
P2860
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
@en
type
label
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
@en
prefLabel
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
@en
P2093
P356
P1433
P1476
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
@en
P2093
Freedman MH
Grunberger T
Kamel-Reid S
Phillips RA
P304
P356
10.1126/SCIENCE.2595371
P407
P4510
P50
P577
1989-12-01T00:00:00Z